Doximity, Inc. (NASDAQ:DOCS – Get Free Report) has received an average rating of “Hold” from the fifteen research firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eleven have given a hold recommendation and three have given a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $28.73.
Several research analysts recently weighed in on DOCS shares. William Blair reissued an “outperform” rating on shares of Doximity in a research report on Friday, May 17th. Morgan Stanley reissued an “underweight” rating and issued a $25.00 price target on shares of Doximity in a research report on Tuesday, April 23rd. Evercore ISI boosted their price objective on shares of Doximity from $28.00 to $29.00 and gave the company an “in-line” rating in a research report on Friday, May 17th. JPMorgan Chase & Co. upgraded shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 target price for the company in a research report on Thursday, April 25th. Finally, Needham & Company LLC restated a “hold” rating on shares of Doximity in a report on Friday, May 17th.
Check Out Our Latest Stock Report on Doximity
Insiders Place Their Bets
Hedge Funds Weigh In On Doximity
Several large investors have recently made changes to their positions in the business. LRI Investments LLC bought a new position in Doximity in the 1st quarter worth approximately $27,000. First Horizon Advisors Inc. grew its stake in shares of Doximity by 111.3% in the fourth quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock worth $28,000 after acquiring an additional 524 shares during the last quarter. GAMMA Investing LLC bought a new position in Doximity during the fourth quarter worth $40,000. DekaBank Deutsche Girozentrale bought a new position in Doximity during the first quarter worth $46,000. Finally, Essex Investment Management Co. LLC acquired a new position in Doximity during the 1st quarter valued at $73,000. Institutional investors and hedge funds own 87.19% of the company’s stock.
Doximity Price Performance
Doximity stock opened at $27.08 on Friday. Doximity has a fifty-two week low of $19.71 and a fifty-two week high of $36.29. The firm’s 50 day simple moving average is $27.15 and its 200-day simple moving average is $27.46. The company has a market cap of $5.02 billion, a P/E ratio of 37.61, a price-to-earnings-growth ratio of 5.08 and a beta of 1.22.
Doximity (NASDAQ:DOCS – Get Free Report) last posted its quarterly earnings data on Thursday, May 16th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.04. The firm had revenue of $118.06 million for the quarter, compared to analysts’ expectations of $116.46 million. Doximity had a net margin of 31.04% and a return on equity of 17.44%. On average, analysts expect that Doximity will post 0.74 EPS for the current fiscal year.
About Doximity
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More
- Five stocks we like better than Doximity
- Learn Technical Analysis Skills to Master the Stock Market
- Sales Breakout Sends This Semiconductor Stock to Record High
- 3 Stocks to Consider Buying in October
- Surprise Buying Opportunity on This Dividend Aristocrat
- Are Penny Stocks a Good Fit for Your Portfolio?
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.